Antidiabetic Effects of Momordica charantia (Karela) in Male long Evans Rat
The hypoglycemic effect of Momordica charantia (Karela) has been reported from many laboratories. To our knowledge, the underlying biochemical mechanism of action of this important clinical effect has not been reported. During the course of investigation of this aspect of the herbal fruit, it was reported from our laboratory that ethanolic extract of Momordica charantia suppressed gluconeogenesis in normal and streptozotocin (STZ) induced diabetic rats by depressing the hepatic gluconeogenic enzymes fructose-1,6-bisphosphatase and glucose-6-phosphatase. The herbal extract had also enhanced the activity of glucose-6-phosphate dehydrogenase, the rate-limiting enzyme of hexose monophosphate shunt (a pathway for the oxidation of glucose).
. Srivastava, J., Lambert, J., Vietmeyer, N. (1996). Medicinal Plants: An expanding role in development. World Bank Technical paper. No. 320.
. Fatope, M., Takeda, Y., Yamashita, H., Okabe, H. and Yamauchi, T. (1990). New cucurbitane triterpenoids from Momordica charantia. Journal of Natural Products, 53(6): 1491-1497.
. Begum, S., Ahmed, M., Siddiqui, B.S., Khan, A., Saify, Z.S. and Arif, M. (1997). Triterpenes, a sterol, and a monocyclic alcohol from Momordica charantia. Phytochemistry, 44(7): 1313-1320.
. Okabe, H., Miyahara, Y. and Yamauci, T. (1982). Studies on the Constituents of Momordica charantia L. IV. Characterization of the New Cucurbitacin Glycosides of the Immature Fruits. (2) Structures of the Bitter Glycosides, Momordicosides K and L. Chemical and Pharmaceutical Bulletin, 30(12): 4334-4340.
. Kimura, Y., Akihisa, T., Yuasa, N., Ukiya, M., Suzuki, T., Toriyama, M., Motohashi, S. and Tokuda, H. (2005). Cucurbitane-type triterpenoids from the fruit of Momordica charantia. Journal of Natural Products, 68 (5): 807-809.
. Chang, C.I., Chen, C.R., Liao, Y.W., Cheng, H.L., Chen, Y.C., and Chou, C.H. (2008). Cucurbitane-type triterpenoids from the stems of Momordica charantia. Journal of Natural Products, 71(8): 1327–1330.
. Akihisa, T., Higo, N., Tokuda, H., Ukiya, M., Akazawa, H., Tochigi, Y., Kimura, Y., Suzuki, T. and Nishino, H. (2007). Cucurbitane-type triterpenoids from the fruits of Momordica charantia and their cancer chemopreventive effects. Journal of Natural Products, 70(3): 1233-1239.
. Ortigao, M. and Better, M. (1992). Momordin II, a ribosome inactivating protein from Momordica balsamina, is homologous to other plant proteins]. Nucleic Acids Research, 20(17): 4662.
. Lolitkar, M.M. and Rajarama Rao, M.R. (1962). Note on a Hypoglycemic Principle Isolated from the fruits of Momordica charantia. Journal of the University of Bombay, 29: 223-224.
. Visarata, N. & Ungsurungsie, M. (1981). Extracts from Momordica charantia L. Quarterly Journal of Crude Drug Research, 19(2-3): 75-80.
. Sridhar, M.G., Vinayagamoorthi, R., Arul Suyambunathan, V., Bobby, Z. and Selvaraj, N. (2008). Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats. British Journal of Nutrition, 99(04): 806-12.
. "Ampalaya tablets out soon for diabetics". GMA News. TV. (March 27, 2007). http://www.gmanews.tv/story/35962/Ampalaya-tablets-out-soon-for-diabetics. Retrieved August 12, 2010.
. Krawinkel, M.B. and Keding, G.B. (July 2006). Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia. Nutr. Rev., 64 (7 Pt 1):331–7.
This work is licensed under a Creative Commons Attribution 4.0 International License.